Bumetanide Injection, Solution
Product Images NDC 0641-6008

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0641-6008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bumetanide Injection Usp 1)

Chemical structure diagram of the active ingredient bumetanide, showing its molecular components including aromatic rings and functional groups such as carboxyl (COOH), sulfonamide (SO2NH2), and ether-linked phenyl (OC6H5).*

FDA Label Image

West-ward Logo (Bumetanide Injection Usp 2)

Bumetanide Injection, USP 1 mg per 4 mL (0.25 mg/mL) injection solution for intravenous or intramuscular use. Contains benzyl alcohol as a preservative. Single dose vial with 4 mL volume. Manufactured by Hikma Pharmaceuticals USA Inc. Label includes dosage and storage information, and non-latex material indication.*

FDA Label Image

Bumetanide Injection, Usp 1 mg/4 mL (0.25 mg/ml) 4 mL Single Dose Vial (Bumetanide Injection Usp 3)

Label for Bumetanide Injection, USP, 1 mg per 4 mL (0.25 mg/mL) injection solution by Hikma Pharmaceuticals USA Inc. The label indicates use for intravenous or intramuscular administration. The package contains 10 single-dose vials of 4 mL each. The label includes storage instructions, preservatives, and buffer components.*

FDA Label Image

Bumetanide Injection, Usp 1 mg/4 mL (0.25 mg/ml) 10 X 4 mL Single Dose Vials (Bumetanide Injection Usp 4)

Label for Bumetanide Injection, USP 2.5 mg per 10 mL (0.25 mg/mL) solution for intravenous or intramuscular use. Contains benzyl alcohol as a preservative. Supplied in a 10 mL multiple dose vial by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Bumetanide Injection, Usp 2.5 mg/10 mL (0.25 mg/ml) 10 mL Multiple Dose Vial (Bumetanide Injection Usp 5)

Label for Bumetanide Injection, USP 0.25 mg/mL solution in 10 mL multiple dose vials. The label states the product contains 2.5 mg per 10 mL and is for intravenous or intramuscular use. It includes storage instructions, preservative information, and is manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Bumetanide Injection, Usp 2.5 mg/10 mL (0.25 mg/ml) 10 X 10 mL Multiple Dose Vials (Bumetanide Injection Usp 6)

Bumetanide injection solution label showing a QR code and various product identifiers including GTIN, serial number, expiration date, and lot number. The label provides traceability information for Hikma Pharmaceuticals USA Inc.'s 0.25 mg/mL strength injectable solution intended for intramuscular or intravenous use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.